(Q29620009)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

30 April 2017

1 reference

intracellular signaling peptides and proteins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

cell cycle proteins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

tumor suppressor proteins

19 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

9

P. J. Farnham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

author name string

Kaelin WG Jr

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

30 April 2017

DeCaprio JA

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

30 April 2017

W. G. Kaelin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

W. Krek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

W. R. Sellers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

J. A. DeCaprio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

F. Ajchenbaum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

C. S. Fuchs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

T. Chittenden

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

Y. Li

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

19 October 2022

M. A. Blanar

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1638635

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

19 October 2022

language of work or name

1 reference

30 April 2017

publication date

24 July 1992

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

full work available at URL

30 April 2017

https://api.elsevier.com/content/article/PII:009286749290108O?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

https://api.elsevier.com/content/article/PII:009286749290108O?httpAccept=text/plain

19 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

19 October 2022

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

30 April 2017

volume

70

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

30 April 2017

issue

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

30 April 2017

page(s)

351-64

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1638635

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

30 April 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1099/0022-1317-36-1-59

Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system

3

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F

19 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

19 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor

19 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells

19 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo

19 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos

19 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

19 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.

19 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The E2F transcription factor is a cellular target for the RB protein

19 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein

19 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

19 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element

19 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression

19 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product

19 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

19 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain

19 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Rapid site-specific mutagenesis in plasmids

19 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

cdc2 gene expression at the G1 to S transition in human T lymphocytes

19 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle

19 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Monoclonal antibodies specific for simian virus 40 tumor antigens

19 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products

19 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F

19 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Role of E2F transcription factor in E1A-mediated trans activation of cellular genes

19 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F

19 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells

19 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides

19 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

19 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex

19 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product

19 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product

19 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product

19 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding

19 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control

19 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Phosphorylation of human immune interferon (IFN-gamma)

19 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements

19 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

How different eukaryotic transcriptional activators can cooperate promiscuously.

19 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family

19 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.

19 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Structure and partial genomic sequence of the human retinoblastoma susceptibility gene

19 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter

19 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins

19 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway

19 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins

19 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Genetic analysis of the adenovirus E4 6/7 trans activator: interaction with E2F and induction of a stable DNA-protein complex are critical for activity

19 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Anatomy of a transcription factor important for the start of the cell cycle in Saccharomyces cerevisiae

19 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Identification of a growth suppression domain within the retinoblastoma gene product

19 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Activation of a preexisting cellular factor as a basis for adenovirus E1A-mediated transcription control

19 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells

19 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product

19 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

19 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

19 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

C-terminal truncation of the retinoblastoma gene product leads to functional inactivation

19 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner

19 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

19 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

Synchronous and sequential activation of latently infected Epstein-Barr virus genomes

19 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding

19 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/0092-8674(92)90108-O

19 October 2022

Identifiers

0 references